JW Pharmaceutical Corporation (KRX:001060)

Market Cap	729.69B +34.6%
Revenue (ttm)	775.30B +7.8%
Net Income	61.51B -5.4%
EPS	2,534.00 -4.2%
Shares Out	22.89M
PE Ratio	12.61
Forward PE	n/a
Dividend	450.00 (1.41%)
Ex-Dividend Date	Mar 31, 2026

Volume	81,759
Average Volume	101,501
Open	31,150
Previous Close	31,000
Day's Range	31,050 - 32,750
52-Week Range	19,600 - 39,250
Beta	1.16
RSI	48.59
Earnings Date	Mar 20, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2025, JW Pharmaceutical's revenue was 775.30 billion, an increase of 7.77% compared to the previous year's 719.38 billion. Earnings were 61.51 billion, a decrease of -5.43%.